News

Long Islanders suffering from sleep apnea inundated the sleep center at St. Charles Hospital in Port Jefferson with phone ...
Resmed CEO Mick Farrell addressed the latest potential threats to the CPAP therapy market during a recent webcast: The ...
An estimated 30 million Americans have sleep apnea, which is defined as recurring episodes of partial or complete airway ...
In today’s Health Alert, obstructive sleep apnea may soon be treated with a simple, once-a-day pill. This first-in-class oral ...
The new pill, called AD109, is a combination of atomoxetine and aroxybutynin, two drugs that tell your brain to keep the ...
Apnimed's experimental drug reduced breathing interruptions by nearly 46.8% in clinical trials, offering a potential ...
Resmed beat Wall Street estimates for fourth-quarter profit on Thursday, driven by strong demand for its devices used to manage sleep apnea. The company makes continuous positive airway pressure (CPAP ...
Just the same, readers are increasingly aware that even sleep comes with risks. Think sleep apnea. The throat muscles of some ...
The first oral pill for obstructive sleep apnea could be around the corner after company Apnimed reported positive results ...
A Behavioral Sleep Medicine Specialist wore CPAP for a year to better empathize with her patients. This is what she learned.
Your CPAP machine isn't going anywhere soon, even with the preliminary positive results of AD109. In the meantime, here are some helpful tips to make sleeping with your CPAP machine easier.
A proposed partial settlement of 20 million CAD has been reached in the Canada-wide class actions against Philips Respironics, addressing economic loss claims related to the recall of certain CPAP, Bi ...